Celsion Corporation Issues Letter to Stockholders
11 févr. 2021 08h30 HE
|
Celsion CORP
Discusses Broad-based DNA Vaccine Initiative, OVATION 2 Study, and Phase III OPTIMA Study Conclusions LAWRENCEVILLE, N.J., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN),...